摘要
原文 | 英語 |
---|---|
頁(從 - 到) | 5211-5216 |
頁數 | 6 |
期刊 | Anticancer Research |
卷 | 38 |
發行號 | 9 |
出版狀態 | 已發佈 - 2018 |
Keywords
- Biomarkers
- Leukoplakia
- Oxidative stress
- Potentially malignant oral disorders
指紋
深入研究「Biomarkers of oxidative stress associated with the risk of potentially malignant oral disorders」主題。共同形成了獨特的指紋。引用此
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
於: Anticancer Research, 卷 38, 編號 9, 2018, p. 5211-5216.
研究成果: 雜誌貢獻 › 文章 › 同行評審
}
TY - JOUR
T1 - Biomarkers of oxidative stress associated with the risk of potentially malignant oral disorders
AU - Senghore, T.
AU - Li, Y.-F.
AU - Sung, F.-C.
AU - Tsai, M.-H.
AU - Hua, C.-H.
AU - Liu, C.-S.
AU - Huang, R.-J.
AU - Yeh, C.-C.
N1 - Export Date: 18 October 2018 CODEN: ANTRD 通訊地址: Yeh, C.-C.; School of Public Health, College of Public Health, Taipei Medical University, 250 Wu-Hsing Street, Taiwan; 電子郵件: [email protected] 化學物質/CAS: deoxyguanosine, 961-07-9; prostaglandin F2 alpha, 551-11-1; 8-epi-prostaglandin F2alpha; 8-oxo-7-hydrodeoxyguanosine; Biomarkers; Deoxyguanosine; Dinoprost 參考文獻: Su, C.-C., Tsai, K.-Y., Hsu, Y.-Y., Lin, Y.-Y., Lian, I.-B., Chronic exposure to heavy metals and risk of oral cancer in Taiwanese males (2010) Oral Oncol, 46 (8), pp. 586-590; Swenberg, J.A., Lu, K., Moeller, B.C., Gao, L., Upton, P.B., Nakamura, J., Starr, T.B., Endogenous versus exogenous DNA adducts: Their role in carcinogenesis, epidemiology, and risk assessment (2011) Toxicol Sci, 120, pp. S130-S145; Valko, M., Rhodes, C.J., Moncol, J., Izakovic, M., Mazur, M., Free radicals, metals and antioxidants in oxidative stress-induced cancer (2006) Chem Biol Interact, 160 (1), pp. 1-40; Marczynski, B., Rozynek, P., Kraus, T., Schlosser, S., Raithel, H.J., Baur, X., Levels of 8-hydroxy-2’-deoxyguanosine in DNA of white blood cells from workers highly exposed to asbestos in Germany (2000) Mutat Res, 468 (2), pp. 195-202; Xing, F., Li, Z., Sun, A., Xing, D., Reactive oxygen species promote chloroplast dysfunction and salicylic acid accumulation in fumonisin B1-induced cell death (2013) FEBS Lett, 587 (14), pp. 2164-2172; Thomson, C.A., Giuliano, A.R., Shaw, J.W., Rock, C.L., Ritenbaugh, C.K., Hakim, I.A., Hollenbach, K.A., Pierce, J.P., Diet and biomarkers of oxidative damage in women previously treated for breast cancer (2005) Nutr Cancer, 51 (2), pp. 146-154; Ma, N., Tagawa, T., Hiraku, Y., Murata, M., Ding, X., Kawanishi, S., 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion (2006) Nitric Oxide, 14 (2), pp. 137-143; Choudhari, S.K., Chaudhary, M., Gadbail, A.R., Sharma, A., Tekade, S., Oxidative and antioxidative mechanisms in oral cancer and precancer: A review (2014) Oral Oncol, 50 (1), pp. 10-18; Sheweita, S.A., Drug-metabolizing enzymes: Mechanisms and functions (2000) Curr Drug Metab, 1 (2), pp. 107-132; Sosa, V., Moliné, T., Somoza, R., Paciucci, R., Kondoh, H., Lleonart, M.E., Oxidative stress and cancer: An overview (2013) Ageing Res Rev, 12 (1), pp. 376-390; Li, Y.F., Sung, F.C., Tsai, M.H., Hua, C.H., Liu, C.S., Huang, Y.T., Yeh, C.C., Interactions between cigarette smoking and polymorphisms of xenobiotic-metabolizing genes: The risk of oral leukoplakia (2013) Dis Markers, 34 (4), pp. 247-255; Kadashetti, V., Shivakumar, K.M., Chaudhary, M., Patil, S., Gawande, M., Hande, A., Influence of risk factors on patients suffering from potentially malignant disorders and oral cancer: A case–control study (2017) J Oral Maxillofac Pathol, 21 (3), pp. 455-456; Warnakulasuriya, S., Johnson, N.W., Van Der Waal, I., Nomenclature and classification of potentially malignant disorders of the oral mucosa (2007) J Oral Pathol Med, 36 (10), pp. 575-580; Speight, P.M., Khurram, S.A., Kujan, O., Oral potentially malignant disorders: Risk of progression to malignancy (2017) Oral Surg Oral Med Oral Pathol Oral Radiol, 125 (6), pp. 612-627; Chiang, C.-J., Lo, W.-C., Yang, Y.-W., You, S.-L., Chen, C.-J., Lai, M.S., Incidence and survival of adult cancer patients in Taiwan, 2002-2012 (2016) J Formos Med Assoc, 115 (12), pp. 1076-1088; Poulsen, H.E., Prieme, H., Loft, S., Role of oxidative DNA damage in cancer initiation and promotion (1998) Eur J Cancer Prev, 7 (1), pp. 9-16; Srivastava, K.C., Shrivastava, D., Analysis of plasma lipid peroxidation and antioxidant enzymes status in patients of oral leukoplakia: A case–control study (2016) J Int Soc Prev Community Dent, 6, pp. S213-s218; Ziech, D., Franco, R., Georgakilas, A.G., Georgakila, S., Malamou-Mitsi, V., Schoneveld, O., Pappa, A., Panayiotidis, M.I., The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development (2010) Chem Biol Interact, 188 (2), pp. 334-339; Kondo, S., Toyokuni, S., Tanaka, T., Hiai, H., Onodera, H., Kasai, H., Imamura, M., Overexpression of the hOGG1 gene and high 8-hydroxy-2’-deoxyguanosine (8-OHdG) lyase activity in human colorectal carcinoma: Regulation mechanism of the 8-OHdG level in DNA (2000) Clin Cancer Res, 6 (4), pp. 1394-1400; Niedernhofer, L.J., Daniels, J.S., Rouzer, C.A., Greene, R.E., Marnett, L.J., Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells (2003) J Biol Chem, 278 (33), pp. 31426-31433; Jr, R.P., Gammon, M.D., Terry, M.B., Agrawal, M., Zhang, F.F., Teitelbaum, S.L., Eng, S.M., Santella, R.M., Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk (2006) Cancer Epidemiol Biomarkers Prev, 15 (4), pp. 639-644; Brys, M., Morel, A., Forma, E., Krzeslak, A., Wilkosz, J., Rozanski, W., Olas, B., Relationship of urinary isoprostanes to prostate cancer occurrence (2013) Mol Cell Biochem, 372 (1-2), pp. 149-153; Freitas Bde, J., Lloret, G.R., Visacri, M.B., Tuan, B.T., Amaral, L.S., Baldini, D., De Sousa, V.M., Moriel, P., High 15-F2t-isoprostane levels in patients with a previous history of nonmelanoma skin cancer: The effects of supplementary antioxidant therapy (2015) Biomed Res Int, 2015, p. 963569; Benamira, M., Johnson, K., Chaudhary, A., Bruner, K., Tibbetts, C., Marnett, L.J., Induction of mutations by replication of malondialdehyde modified M13 DNA in Escherichia coli: Determination of the extent of DNA modification, genetic requirements for mutagenesis, and types of mutations induced (1995) Carcinogenesis, 16 (1), pp. 93-99; Liu, H., Jia, J., Mao, X., Lin, Z., Association of CYP1A1 and GSTM1 polymorphisms with oral cancer susceptibility: A meta-analysis (2015) Medicine, 94 (27), p. e895; Chole, R.H., Patil, R.N., Basak, A., Palandurkar, K., Bhowate, R., Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse (2010) J Cancer Res Ther, 6 (4), pp. 487-491; Valko, M., Jomova, K., Rhodes, C.J., Kuca, K., Musilek, K., Redox- And non-redox-metal-induced formation of free radicals and their role in human disease (2016) Arch Toxicol, 90 (1), pp. 1-37; He, P., Wei, M., Wang, Y., Liu, Q., Associations among glutathione S-transferase T1, M1, and P1 polymorphisms and the risk of oral leukoplakia (2016) Genet Test Mol Biomarkers, 20 (6), pp. 312-321
PY - 2018
Y1 - 2018
N2 - Aim: To investigate the effect of oxidative stress biomarkers on the risk of potentially malignant oral disorders (PMODs). Materials and Methods: A total of 208 male adults with PMODs and an equal number of same-age control patients were enrolled. Plasma biomarkers of oxidative stress, measured with 8-hydroxy-2’-deoxyguanosine (8-OHdG) and 8-isoprostane (8-ISO), were determined using enzyme-linked immunosorbent assay (ELISA) kits. PMODs were diagnosed in accordance with the World Health Organization (WHO) guidelines. Results: A significant association between a high level of 8-ISO and an increased risk of PMODs was identified [odds ratio (OR)=1.71, 95% confidence interval (CI)=1.12-2.63; p=0.013]. This positive association was stronger among patients with PMOD subtype of leukoplakia (OR=1.94, 95% Cl=1.24-3.06; p=0.004). However, no significant association was observed between plasma 8-OHdG levels and overall risk of PMODs or subtypes. Conclusion: Increased plasma 8-ISO levels may indicate the prominence of lipid peroxidation in the development of PMODs, particularly leukoplakia. © 2018 International Institute of Anticancer Research. All rights reserved.
AB - Aim: To investigate the effect of oxidative stress biomarkers on the risk of potentially malignant oral disorders (PMODs). Materials and Methods: A total of 208 male adults with PMODs and an equal number of same-age control patients were enrolled. Plasma biomarkers of oxidative stress, measured with 8-hydroxy-2’-deoxyguanosine (8-OHdG) and 8-isoprostane (8-ISO), were determined using enzyme-linked immunosorbent assay (ELISA) kits. PMODs were diagnosed in accordance with the World Health Organization (WHO) guidelines. Results: A significant association between a high level of 8-ISO and an increased risk of PMODs was identified [odds ratio (OR)=1.71, 95% confidence interval (CI)=1.12-2.63; p=0.013]. This positive association was stronger among patients with PMOD subtype of leukoplakia (OR=1.94, 95% Cl=1.24-3.06; p=0.004). However, no significant association was observed between plasma 8-OHdG levels and overall risk of PMODs or subtypes. Conclusion: Increased plasma 8-ISO levels may indicate the prominence of lipid peroxidation in the development of PMODs, particularly leukoplakia. © 2018 International Institute of Anticancer Research. All rights reserved.
KW - Biomarkers
KW - Leukoplakia
KW - Oxidative stress
KW - Potentially malignant oral disorders
KW - 8 hydroxydeoxyguanosine
KW - 8 isoprostane
KW - biological marker
KW - genomic DNA
KW - 8-epi-prostaglandin F2alpha
KW - 8-oxo-7-hydrodeoxyguanosine
KW - deoxyguanosine
KW - prostaglandin F2 alpha
KW - adult
KW - alcohol consumption
KW - areca nut
KW - Article
KW - cancer risk
KW - case control study
KW - cigarette smoking
KW - controlled study
KW - DNA isolation
KW - enzyme linked immunosorbent assay
KW - genotyping technique
KW - human
KW - leukoplakia
KW - lipid peroxidation
KW - major clinical study
KW - male
KW - malignant transformation
KW - mastication
KW - measurement
KW - mouth cancer
KW - oxidative stress
KW - potentially malignant oral disorder
KW - priority journal
KW - protein blood level
KW - risk assessment
KW - risk factor
KW - analogs and derivatives
KW - blood
KW - middle aged
KW - mouth tumor
KW - precancer
KW - Adult
KW - Deoxyguanosine
KW - Dinoprost
KW - Humans
KW - Lipid Peroxidation
KW - Male
KW - Middle Aged
KW - Mouth Neoplasms
KW - Oxidative Stress
KW - Precancerous Conditions
KW - Risk Factors
KW - Biomarkers
KW - Leukoplakia
KW - Oxidative stress
KW - Potentially malignant oral disorders
M3 - Article
SN - 0250-7005
VL - 38
SP - 5211
EP - 5216
JO - Anticancer Research
JF - Anticancer Research
IS - 9
ER -